BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32268004)

  • 1. Expanding the Versatility of Microbial Transglutaminase Using α-Effect Nucleophiles as Noncanonical Substrates.
    Chio TI; Demestichas BR; Brems BM; Bane SL; Tumey LN
    Angew Chem Int Ed Engl; 2020 Aug; 59(33):13814-13820. PubMed ID: 32268004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial transglutaminase displays broad acyl-acceptor substrate specificity.
    Gundersen MT; Keillor JW; Pelletier JN
    Appl Microbiol Biotechnol; 2014 Jan; 98(1):219-30. PubMed ID: 23615739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous enzyme-coupled assay for microbial transglutaminase activity.
    Oteng-Pabi SK; Keillor JW
    Anal Biochem; 2013 Oct; 441(2):169-73. PubMed ID: 23877008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illuminating structure and acyl donor sites of a physiological transglutaminase substrate from Streptomyces mobaraensis.
    Juettner NE; Schmelz S; Bogen JP; Happel D; Fessner WD; Pfeifer F; Fuchsbauer HL; Scrima A
    Protein Sci; 2018 May; 27(5):910-922. PubMed ID: 29430769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring Activity and Selectivity of Microbial Transglutaminase.
    Deweid L; Avrutina O; Kolmar H
    Methods Mol Biol; 2019; 2012():151-169. PubMed ID: 31161508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorescence-based array screen for transglutaminase substrates.
    Malešević M; Migge A; Hertel TC; Pietzsch M
    Chembiochem; 2015 May; 16(8):1169-74. PubMed ID: 25940638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal peptide of the transglutaminase-activating metalloprotease inhibitor from Streptomyces mobaraensis accommodates both inhibition and glutamine cross-linking sites.
    Juettner NE; Schmelz S; Anderl A; Colin F; Classen M; Pfeifer F; Scrima A; Fuchsbauer HL
    FEBS J; 2020 Feb; 287(4):708-720. PubMed ID: 31420998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaching transglutaminase from Streptomyces bacteria over three decades.
    Fuchsbauer HL
    FEBS J; 2022 Aug; 289(16):4680-4703. PubMed ID: 34102019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificity analysis of microbial transglutaminase using proteinaceous protease inhibitors as natural model substrates.
    Taguchi S; Nishihama KI; Igi K; Ito K; Taira H; Motoki M; Momose H
    J Biochem; 2000 Sep; 128(3):415-25. PubMed ID: 10965040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Versatility of microbial transglutaminase.
    Strop P
    Bioconjug Chem; 2014 May; 25(5):855-62. PubMed ID: 24694238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered, highly reactive substrates of microbial transglutaminase enable protein labeling within various secondary structure elements.
    Rachel NM; Quaglia D; Lévesque É; Charette AB; Pelletier JN
    Protein Sci; 2017 Nov; 26(11):2268-2279. PubMed ID: 28857311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New fluorescent substrates of microbial transglutaminase and its application to peptide tag-directed covalent protein labeling.
    Kamiya N; Abe H
    Methods Mol Biol; 2011; 751():81-94. PubMed ID: 21674327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of preferred substrate sequences of microbial transglutaminase from Streptomyces mobaraensis using a phage-displayed peptide library.
    Sugimura Y; Yokoyama K; Nio N; Maki M; Hitomi K
    Arch Biochem Biophys; 2008 Sep; 477(2):379-83. PubMed ID: 18616926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed Evolution of a Bond-Forming Enzyme: Ultrahigh-Throughput Screening of Microbial Transglutaminase Using Yeast Surface Display.
    Deweid L; Neureiter L; Englert S; Schneider H; Deweid J; Yanakieva D; Sturm J; Bitsch S; Christmann A; Avrutina O; Fuchsbauer HL; Kolmar H
    Chemistry; 2018 Oct; 24(57):15195-15200. PubMed ID: 30047596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a microbial transglutaminase enabling highly site-specific labeling of proteins.
    Steffen W; Ko FC; Patel J; Lyamichev V; Albert TJ; Benz J; Rudolph MG; Bergmann F; Streidl T; Kratzsch P; Boenitz-Dulat M; Oelschlaegel T; Schraeml M
    J Biol Chem; 2017 Sep; 292(38):15622-15635. PubMed ID: 28751378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific protein labelling and immobilization mediated by microbial transglutaminase.
    Oteng-Pabi SK; Pardin C; Stoica M; Keillor JW
    Chem Commun (Camb); 2014 Jun; 50(50):6604-6. PubMed ID: 24824734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual, Site-Specific Modification of Antibodies by Using Solid-Phase Immobilized Microbial Transglutaminase.
    Spycher PR; Amann CA; Wehrmüller JE; Hurwitz DR; Kreis O; Messmer D; Ritler A; Küchler A; Blanc A; Béhé M; Walde P; Schibli R
    Chembiochem; 2017 Oct; 18(19):1923-1927. PubMed ID: 28771896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic activity and thermoresistance of improved microbial transglutaminase variants.
    Böhme B; Moritz B; Wendler J; Hertel TC; Ihling C; Brandt W; Pietzsch M
    Amino Acids; 2020 Feb; 52(2):313-326. PubMed ID: 31350615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific mutation of transglutaminase gene from
    Wan W; He D; Xue Z; Zhang Z
    J Biosci; 2017 Dec; 42(4):537-546. PubMed ID: 29229872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of a glutamine donor mimicking inhibitory peptide shaped by the catalytic cleft of microbial transglutaminase.
    Juettner NE; Schmelz S; Kraemer A; Knapp S; Becker B; Kolmar H; Scrima A; Fuchsbauer HL
    FEBS J; 2018 Dec; 285(24):4684-4694. PubMed ID: 30318745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.